In vitro culture of infiltrating lymphocytes from coronary arteries and endomyocardial biopsies: association with graft coronary disease.
Christina L. Kaufman(University of Louisville), René J. Duquesnoy(University of Pittsburgh Medical Center), Robert L. Kormos(Abbott Northwestern Hospital), Barry F. Uretsky(Central Arkansas Veterans Healthcare System), Adriana Zeevi(University of Pittsburgh), J. O. Armitage(Unknown), B. Griffith(University of Maryland Medical Center), Rotert L. Hardesty, Tony R. Zerbe(University of Pittsburgh), Robert T. Keenan(VA NY Harbor Healthcare System)
PubMed
February 1, 1991
Cited by 5
Related Papers
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
|Transplantation|2012|777
Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups
|American Journal of Transplantation|2010|760
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
|American Journal of Transplantation|2016|625